Full-colour touchscreen with
an easy-to-use interface
2 sampling options
Breath testing by mouthpiece or
by facemask for infant/elderly patients
who struggle to hold their breath
Built-in testing protocols with
built-in countdown timer
An ergonomic design, fully portable and
incorporated with SteriTouch® technology
for optimum infection control
Create and store up to 10 patient
profiles to view a graph of their results
Test all 10 patients at one time
even with different protocols
Technical Specification of the Gastro+™
whichever is greater*
Sensor operating life
3 x AA batteries
(up to 1000 minutes)
CO cross interference
*Readings of >200ppm at temperature between 26-35ᵒC can decrease accuracy to 15%.
As easy as…
SteriBreath™ mouthpieces are individually sealed for optimum infection control.
Condensation confirms an accurate breath sample. SteriBreath™ mouthpieces are attached to the monitor via the D-piece™.
The facemask adaptor is single-patent-use. A facemask is attached to one end and then the sampling system connects to the monitor via the D-piece™.
Monitor cleaning wipes
Free from alcohol to ensure continued performance of your monitor. Products containing alcohol cannot be used on any of the Gastrolyzer range. Pack of 50 wipes.
The OneBreath™ incorporates a one-way valve and an infection control filter, which are proven to remove and trap >99.9% of airborne bacteria1.
The D-piece™ incorporates a one-way
valve and an integrated infection control filter
which removes and traps >99% of airborne bacteria
and >96% of viruses. The D-piece™
should be changed every four weeks.
Facemasks are single-patent-use and
allow the patient to breathe normally
to produce a breath sample. There are
3 sizes: Large, Medium, and Small.
The Gastro+ requires calibration
every 3 months using 100ppm H2 gas,
provided as a kit or replacement cylinder.
The Gastrolyzer® monitors are products from Bedfont® Scientific Ltd.
Incorporated in England and Wales under registered number: 1289798
1. Public Health England. An Evaluation of Filtration Efficiencies Against Bacterial and Viral Aerosol Challenges Report No. 17/001. London: Public Health England; 2017